Detalhe da pesquisa
1.
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial.
Brain Behav Immun
; 115: 191-200, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848096
2.
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
Front Immunol
; 9: 2230, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30364161
3.
Suicide Rates After Discharge From Psychiatric Facilities: A Systematic Review and Meta-analysis.
JAMA Psychiatry
; 74(7): 694-702, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564699
4.
Personality disorder services in England: findings from a national survey.
BJPsych Bull
; 41(5): 247-253, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018548